Missing/wrong data?
Log in to edit
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.
scientific article published on 23 February 2015
Author/s
author: Keith Fox, Philippe Gabriel Steg, Marc S Sabatine, Pierre Théroux, Philip Aylward
Work details
Publication date
February 23, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.